Vazyme Biotech Co.
Latest round
- Series C
Last raised
- May 2020
Total raised
- $80M
Investors
- 8
About Vazyme Biotech Co.
,Ltd. is a biotech company that focuses on R&D of biological reagents, in vitro diagnostic reagents, and antibody drugs. The company has more than 400 R&D team members who developed more than 200 genetic engineering recombinases, more than 1,000 antigens and monoclonal antibodies, and more than 500 end products. The company has built point-of-care testing (POCT) product line. The biological reagents served for more than 1,000 research institutions, more than 1600 companies. Besides, it's in vitro diagnostic reagents served more than 2,200 healthcare institutions. Up to June 2021, it has 50 patents, and 67 medical device registration certificates. It has won many honors, including Postdoctoral Innovation Practice Base of Jiangsu Province, Jiangsu Science and Technology Little Giant Enterprise. The company provides biological reagents, in vitro diagnostic reagents, and antibody drugs. The biological reagents are more than 500, divided into many series, such as polymerase chain reaction (PCR) series, qPCR series, molecular cloning, gene sequencing, which used in the field of scientific research, high-throughput sequencing, and vaccine research and development. The in vitro diagnostic reagents has eight products series, including cardio-cerbral blood vessel, prenatal and postnatal care, and stomach function. The company plans to build research and development base, and expand marketing network.
Who invested in Vazyme Biotech Co.
8 investors across 5 rounds
See all investors in Vazyme Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vazyme Biotech Co.
Who invested in Vazyme Biotech Co.?
Vazyme Biotech Co. has 8 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vazyme Biotech Co. raised?
Vazyme Biotech Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Vazyme Biotech Co. last raise money?
Vazyme Biotech Co.'s most recent round on record is a Series C, in May 2020.
What does Vazyme Biotech Co. do?
Vazyme Biotech Co. is a biotechnology company.
Where is Vazyme Biotech Co. headquartered?
Vazyme Biotech Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Vazyme Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Vazyme Biotech Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Vazyme Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.